Prostate Cancer Advance, and Europeans Free Riding on American Research
by Mike Kimel There’s a story going around in the news about a new prostate cancer drug. Here’s press release: A life-extending new drug to treat patients with advanced prostate cancer, developed by The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, has received its UK license. Abiraterone acetate, marketed by Janssen under […]